Invasion is a genetic program regulated by transcription factors

Current Opinion in Genetics and Development

Volumn 16, Issue 1, 2006, Pages 65-70

  Ozanne, Bradford W ^a   Spence, Heather J ^a   McGarry, Lynn C ^a   Hennigan, Robert F ^b  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; HERMES ANTIGEN; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; MOESIN; PROTEIN P16INK4A; PROTEIN P53; RADIXIN; RHO KINASE; TELOMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

CANCER THERAPY; DROSOPHILA; GENE ACTIVITY; GENE EXPRESSION; GENE REPRESSION; GENETIC ANALYSIS; LAMELLIPODIUM; METASTASIS; PRIORITY JOURNAL; PSEUDOPODIUM; REVIEW; TUMOR CELL;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; HUMANS; NEOPLASM INVASIVENESS; ONCOGENES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

PSEUDOPODA;

EID: 30644456673     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2005.12.012     Document Type: Review

References (65)

1. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
2. A. Gentile, and P.M. Comoglio Invasive growth: a genetic program Int J Dev Biol 48 2004 451 456 A good review, highlighting the role of invasive growth in development and cancer.
3. E. Sahai Mechanisms of cancer cell invasion Curr Opin Genet Dev 15 2005 87 96
4. S. Meng, D. Tripathy, E.P. Frenkel, S. Shete, E.Z. Naftalis, J.F. Huth, P.D. Beitsch, M. Leitch, S. Hoover, and D. Euhus Circulating tumor cells in patients with breast cancer dormancy Clin Cancer Res 10 2004 8152 8162
5. I. Weissman Stem cell research: paths to cancer therapies and regenerative medicine Jama 294 2005 1359 1366
6. H. Yamaguchi, J. Wyckoff, and J. Condeelis Cell migration in tumors Curr Opin Cell Biol 17 2005 559 564
7. J.A. Burger, and T.J. Kipps CXCR4: A key receptor in the cross talk between tumor cells and their microenvironment Blood 2005 DOI:10.1182/blood- 2005-08-3182
8. E. Vial, E. Sahai, and C.J. Marshall ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility Cancer Cell 4 2003 67 79 Insightful study that demonstrates that Fra1 expression is necessary for invasion of human colon cancer cells that express an activated H-RAS gene.
9. A. Malliri, M. Symons, R.F. Hennigan, A.F. Hurlstone, R.F. Lamb, T. Wheeler, and B.W. Ozanne The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells J Cell Biol 143 1998 1087 1099
10. R. Muller, R. Bravo, J. Burckhardt, and T. Curran Induction of c-fos gene and protein by growth factors precedes activation of c-myc Nature 312 1984 716 720
11. K. Murai, and R. Treisman Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1 Mol Cell Biol 22 2002 7083 7092
12. I.M. Johnston, H.J. Spence, J.N. Winnie, L. McGarry, J.K. Vass, L. Meagher, G. Stapleton, and B.W. Ozanne Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion Oncogene 19 2000 5348 5358
13. J.P. Thiery Epithelia-mesenchymal transitions in development and pathologies Curr Opin Cell Biol 15 2003 740 746
14. K. Hemavathy, S.I. Ashraf, and Y.T. Ip Snail/slug family of repressors: slowly going into the fast lane of development and cancer Gene 257 2000 1 12
15. J. Zavadil, and E.P. Bottinger TGF-β and epithelial-to-mesenchymal transitions Oncogene 24 2005 5764 5774 The authors highlight the role of TGFβ in EMT.
16. R. Derynck, R.J. Akhurst, and A. Balmain TGF-β signaling in tumor suppression and cancer progression Nat Genet 29 2001 117 129
17. Z. Lu, S. Ghosh, Z. Wang, and T. Hunter Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion Cancer Cell 4 2003 499 515
18. L. Pertovaara, L. Sistonen, T.J. Bos, P.K. Vogt, J. Keski-Oja, and K. Alitalo Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation Mol Cell Biol 9 1989 1255 1262
19. M. Davies, M. Robinson, E. Smith, S. Huntley, S. Prime, and I. Paterson Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways J Cell Biochem 95 2005 918 931 A recent study that demonstrates the connection between TGFβ signalling and transcription in the regulation of EMT.
20. S. Ried, C. Jager, M. Jeffers, G.F. Vande Woude, H. Graeff, M. Schmitt, and E. Lengyel Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor J Biol Chem 274 1999 16377 16386
21. E. Reichmann, H. Schwarz, E.M. Deiner, I. Leitner, M. Eilers, J. Berger, M. Busslinger, and H. Beug Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion Cell 71 1992 1103 1116
22. H. Peinado, M. Quintanilla, and A. Cano Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions J Biol Chem 278 2003 21113 21123
23. E. Saez, S.E. Rutberg, E. Mueller, H. Oppenheim, J. Smoluk, S.H. Yuspa, and B.M. Spiegelman c-fos is required for malignant progression of skin tumors Cell 82 1995 721 732
24. M.R. Young, J.J. Li, M. Rincon, R.A. Flavell, B.K. Sathyanarayana, R. Hunziker, and N. Colburn Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion Proc Natl Acad Sci USA 96 1999 9827 9832
25. R. Eferl, and E.F. Wagner AP-1: a double-edged sword in tumorigenesis Nat Rev Cancer 3 2003 859 868
26. T. Curran, G. Peters, C. Van Beveren, N.M. Teich, and I.M. Verma FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA J Virol 44 1982 674 682
27. T. Curran, A.D. Miller, L. Zokas, and I.M. Verma Viral and cellular fos proteins: a comparative analysis Cell 36 1984 259 268
28. Y. Maki, T.J. Bos, C. Davis, M. Starbuck, and P.K. Vogt Avian sarcoma virus 17 carries the jun oncogene Proc Natl Acad Sci USA 84 1987 2848 2852
29. T.J. Bos, D. Bohmann, H. Tsuchie, R. Tjian, and P.K. Vogt v-jun encodes a nuclear protein with enhancer binding properties of AP-1 Cell 52 1988 705 712
30. A.D. Miller, T. Curran, and I.M. Verma c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene Cell 36 1984 51 60
31. T. Jenuwein, D. Muller, T. Curran, and R. Muller Extended life span and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV Cell 41 1985 629 637
32. G.G. Miao, and T. Curran Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle Mol Cell Biol 14 1994 4295 4310
33. R.F. Hennigan, K.L. Hawker, and B.W. Ozanne Fos-transformation activates genes associated with invasion Oncogene 9 1994 3591 3600
34. J. Westermarck, and V.M. Kahari Regulation of matrix metalloproteinase expression in tumor invasion Faseb J 13 1999 781 792
35. R.F. Lamb, R.F. Hennigan, K. Turnbull, K.D. Katsanakis, E.D. MacKenzie, G.D. Birnie, and B.W. Ozanne AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44 Mol Cell Biol 17 1997 963 976
36. J.M. Ordway, S.D. Fenster, H. Ruan, and T. Curran A transcriptome map of cellular transformation by the fos oncogene Mol Cancer 4 2005 19 An important map of the Fos oncogene transcriptome.
37. J.M. Ordway, K. Williams, and T. Curran Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1 Oncogene 23 2004 3737 3748 The authors demonstrate that downregulation of tumour suppressor genes targets common genes in cells expressing a variety of oncogenic proteins.
38. B.W. Ozanne, L. McGarry, H.J. Spence, I. Johnston, J. Winnie, L. Meagher, and G. Stapleton Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme Eur J Cancer 36 2000 1640 1648
39. H.J. Spence, I. Johnston, K. Ewart, S.J. Buchanan, U. Fitzgerald, and B.W. Ozanne Krp1, a novel kelch related protein that is involved in pseudopod elongation in transformed cells Oncogene 19 2000 1266 1276
40. R.F. Lamb, B.W. Ozanne, C. Roy, L. McGarry, C. Stipp, P. Mangeat, and D.G. Jay Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts Curr Biol 7 1997 682 688
41. Spence HJ, McGarry LC, Chew CS, Carragher NO, Scott-Carragher LA, Yuan Z, Croft DR, Olson MF, Frame M, and Ozanne BW: AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK independent mesenchymal invasion by altering the function, localisation and activity of non-differentially expressed proteins. Mol Cell Biol 2006, in press. Supports the concept of an invasion program, by demonstrating that both upregulated and downregulated genes cooperate to enhance invasion by altering the function, location and activity of proteins that are not differentially expressed.
42. G. Tzircotis, R.F. Thorne, and C.M. Isacke Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding J Cell Sci 118 2005 5119 5128
43. R. Marhaba, and M. Zoller CD44 in cancer progression: adhesion, migration and growth regulation J Mol Histol 35 2004 211 231
44. K.U. Jooss, and R. Muller Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation Oncogene 10 1995 603 608
45. Y. Yu, J. Khan, C. Khanna, L. Helman, P.S. Meltzer, and G. Merlino Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators Nat Med 10 2004 175 181
46. C. Khanna, X. Wan, S. Bose, R. Cassaday, O. Olomu, A. Mendoza, C. Yeung, R. Gorlick, S.M. Hewitt, and L.J. Helman The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 10 2004 182 186
47. B.E. Elliott, J.A. Meens, S.K. SenGupta, D. Louvard, and M. Arpin The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells Breast Cancer Res 7 2005 R365 R373
48. W.H. Weng, J. Ahlen, K. Astrom, W.O. Lui, and C. Larsson Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas Clin Cancer Res 11 2005 6198 6204
49. J. Adams, R. Kelso, and L. Cooley The kelch repeat superfamily of proteins: propellers of cell function Trends Cell Biol 10 2000 17 24
50. A.V. Bakin, and T. Curran Role of DNA 5-methylcytosine transferase in cell transformation by fos Science 283 1999 387 390
51. L.C. McGarry, J.N. Winnie, and B.W. Ozanne Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes Oncogene 23 2004 5284 5292 Demonstrates that Fos-stimulated invasion is very sensitive to HDAC inhibitors.
52. L.A. Scott, J.K. Vass, E.K. Parkinson, D.A. Gillespie, J.N. Winnie, and B.W. Ozanne Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53 Mol Cell Biol 24 2004 1540 1559 Demonstrates that Fos-induced invasion can occur early in tumour progression.
53. F. McGregor, A. Muntoni, J. Fleming, J. Brown, D.H. Felix, D.G. MacDonald, E.K. Parkinson, and P.R. Harrison Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine Cancer Res 62 2002 4757 4766
54. P.H. Brown, R. Alani, L.H. Preis, E. Szabo, and M.J. Birrer Suppression of oncogene-induced transformation by a deletion mutant of c-jun Oncogene 8 1993 877 886
55. G. Stapleton, A. Malliri, and B.W. Ozanne Downregulated AP-1 activity is associated with inhibition of Protein-Kinase-C-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells J Cell Sci 115 2002 2713 2724
56. M. Bahassi el, S. Karyala, C.R. Tomlinson, M.A. Sartor, M. Medvedovic, and R.F. Hennigan Critical regulation of genes for tumor cell migration by AP-1 Clin Exp Metastasis 21 2004 293 304
57. H.L. Wang, J. Wang, S.Y. Xiao, R. Haydon, D. Stoiber, T.C. He, M. Bissonnette, and J. Hart Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin Int J Cancer 101 2002 301 310
58. G. Chiappetta, G. Tallini, M.C. De Biasio, F. Pentimalli, F. de Nigris, S. Losito, M. Fedele, S. Battista, P. Verde, and M. Santoro FRA-1 expression in hyperplastic and neoplastic thyroid diseases Clin Cancer Res 6 2000 4300 4306
59. Y.C. Hu, K.Y. Lam, S. Law, J. Wong, and G. Srivastava Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC Clin Cancer Res 7 2001 2213 2221
60. H. Andersen, S. Mahmood, V. Tkach, M. Cohn, O. Kustikova, M. Grigorian, V. Berezin, E. Bock, E. Lukanidin, and E. Tulchinsky The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials Oncogene 21 2002 4843 4848
61. H. Andersen, J. Mejlvang, S. Mahmood, I. Gromova, P. Gromov, E. Lukanidin, M. Kriajevska, J.K. Mellon, and E. Tulchinsky Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells Mol Cell Biol 25 2005 9138 9150
62. O. Kustikova, D. Kramerov, M. Grigorian, V. Berezin, E. Bock, E. Lukanidin, and E. Tulchinsky Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells Mol Cell Biol 18 1998 7095 7105
63. V. Tkach, E. Tulchinsky, E. Lukanidin, C. Vinson, E. Bock, and V. Berezin Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility Oncogene 22 2003 5045 5054
64. Y. Luo, H. Zhou, M. Mizutani, N. Mizutani, R.A. Reisfeld, and R. Xiang Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine Proc Natl Acad Sci USA 100 2003 8850 8855 The authors demonstrate that targeting AP-1 component proteins is an effective means of suppressing tumours in a mouse model system.
65. Y. Luo, H. Zhou, M. Mizutani, N. Mizutani, C. Liu, R. Xiang, and R.A. Reisfeld A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence Cancer Res 65 2005 3419 3427